At UCLA, comprehensive care for colorectal cancer is provided through the Gastrointestinal Oncology Program.
The Gastrointestinal Oncology Program
The Gastrointestinal (GI) Oncology Program treats a wide variety of malignant conditions of the gastrointenstinal tract, including colorectal cancer as well as cancers of the anus, stomach, esophagus, pancreas, bile duct, gallbladder in addition to GISTs (gastrointestinal stromal tumors) and carcinoid tumors.
Through the GI Oncology program, UCLA offer patients with colorectal cancer multi-specialty coordination with experts in the fields of surgery, medical oncology, radiation oncology, radiology, nursing and social work.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
Colorectal cancer patients who come to UCLA also benefit from the most advanced forms of therapy available and have access to the latest protocols through the Gastrointestinal Oncology clinical research unit.
If you are interested in finding out more about these studies, visit our Clinical Trials Guide for general information and a listing of currently open clinical trials.
For more information on colorectal cancer services at UCLA, visit the following related website: